Slotnik Capital »

Atrium Therapeutics shares owned by Slotnik Capital

Quarter-by-quarter ownership of Atrium Therapeutics (RNA) shares owned by Slotnik Capital from 13F filings

Historical chart of Slotnik Capital investment in Atrium Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atrium Therapeutics held by Slotnik Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atrium Therapeutics by Slotnik Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.4M 181k 13.37

More positions owned by Slotnik Capital

Chart Industries (GTLS)
Masimo Corporation
Penumbra (PEN)
Terns Pharmaceuticals (TERN)
Liberty Broadband Corp Com Ser A (LBRDA)
Webster Financial Corporation (WBS)
Warner Bros Discovery Com Ser A (WBD)
Mission Produce (AVO)
Kenvue (KVUE)
Silicon Laboratories (SLAB)
Arcellx Common Stock (ACLX)
Aris Mng Corp (ARIS)
Liberty Broadband Corp Com Ser C (LBRDK)
Tri Pointe Homes
Western Midstream Partners L Com Unit Lp Int (WES)

View all positions for Slotnik Capital

Top funds holding Atrium Therapeutics

T. Rowe Price Associates
BlackRock
Susquehanna International
RA Capital Management
Vanguard Capital Management
TIG Advisors
Pentwater Capital Management
Sessa Capital IM
Goldman Sachs Group
Farallon Capital Management
Vanguard Portfolio Management
Geode Capital Management
683 Capital Management
Bellevue Group
State Street Corporation

View all funds holding Atrium Therapeutics